We determined that IRS could increase LYZ expression in gene‐edited GMEC and attenuate the inflammatory response; however, further validation is needed to determine whether IRS can increase LYZ expression in individuals and thereby reduce the severity of mastitis. The gene discussed is IARS1; the disease is mastitis.